Scientific Advisory Board:
José Duca, Ph.D., Head, Computer Aided Drug Discovery, Novartis
Alan C. Rigby, Ph.D., Vice President, Research, Computational Discovery, ImClone Systems-A wholly-owned subsidiary of Eli Lilly and Company
Tomi Sawyer, Ph.D., CSO, Aileron Therapeutics, Inc.; Editor-in-Chief, Chemical Biology & Drug Design
Woody Sherman, Ph.D., Vice President, Applications Science, Schrödinger, Inc.
Gergely Toth, Ph.D., Research Fellow, Department of Chemistry, University of Cambridge
Marcel Verdonk, Ph.D., Director, Computational Chemistry and Informatics, Astex Therapeutics Ltd.
Pat Walters, Ph.D., Senior Research Fellow, Vertex Pharmaceuticals, Inc.
Chris Williams, Ph.D., Principal Scientist, Chemical Computing Group